Skip to content

Safety and Efficacy of Fentanyl Citrate in Children

Safety and Efficacy of Fentanyl Citrate in Combination With Midazolam in Critically Ill Children With Mechanical Ventilation

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02172014
Enrollment
44
Registered
2014-06-24
Start date
2013-06-30
Completion date
2015-01-31
Last updated
2015-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children

Keywords

Mechanical Ventilation, Sedation, Fentanyl, Midazolam, Comfort behavior scale

Brief summary

Title: Safety and efficacy of fentanyl citrate in combination with midazolam in critically ill children with mechanical ventilation Objective: To evaluate the safety and efficacy of fentanyl citrate in combination with midazolam in children with mechanical ventilation. Design: Double-blind randomized controlled study Patients: Patients age 2 months through 18 years who are admitted in Seoul National University Hospital pediatric intensive care unit, and applied with mechanical ventilation. Interventions: After enrollment of patient, blind reagent (fentanyl citrate or normal saline) is prepared by assigned pharmacist. Investigators, caregivers, patient, and parents of the patient don't know whether the blind reagent is fentanyl citrate or not, but only preparing pharmacist knows that. Protocol: All enrolled patients receive continuous infusion of midazolam and blind reagent. The start time of study is when the continuous infusion of midazolam and blind reagent are begun. Assigned research nurse check Comfort behavior scale of the patient every hour regularly, and whenever the patient seem to be overactive. Endpoint of the study is 48 hours after begining. If there is any adverse effect or unexpected event, however, the study can be early terminated.

Detailed description

Comfort behavior scale consists of 7 components of alertness, calmness, respiratory response, crying, physical movement, muscle tone, and facial tension. Because intubated patients cannot be evaluated 'crying', however, we use 6 components among total of all 7 components, except 'crying'. Adverse effect of fentanyl include hypotension, coma, and ileus. Unexpected event means the situation which study cannot last in, such as withdrawal of consent, necessity of drugs which can affect the level of consciousness of the patient, emergent interventional procedure, etc.

Interventions

DRUGmidazolam and fentanyl citrate infusion

comparing the sedative effect of combination of midazolam and fentanyl citrate versus combination of midazolam and normal saline for 48 hours during ventilator care

DRUGmidazolam and normal saline infusion

comparing the sedative effect of combination of midazolam and fentanyl citrate versus combination of midazolam and normal saline for 48 hours during ventilator care

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
2 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* children mechanically ventilated * age : from 2 months to 18 years

Exclusion criteria

* children with neurologic disease * children with drugs which can affect the level of consciousness * children with renal disease * children with hypotension (systolic blood pressure \< 70 + (2 x age in year) mmHg)

Design outcomes

Primary

MeasureTime frame
difference between measured Comfort behavior scale and target Comfort behavior scalefrom the start of fentanyl/placebo infusion to 48 hours after start of infusion

Secondary

MeasureTime frameDescription
adverse effectfrom the start of fentanyl/placebo infusion to 48 hour after start of infusioncategory of adverse effects 1. hypotension 2. coma 3. ileus
renal dysfunctionfrom the start of fentanyl/placebo infusion to 48 hour after start of infusionestimate GFR (Schwartz equation) \< 50 mL/minute/1.73m2
sedation failurefrom the start of fentanyl/placebo infusion to 48 hour after start of infusionthe case that can't reach target level of sedation, even though use of maximal infusion rate of midazolam and blind reagent.
mortalityfrom the start of fentanyl/placebo infusion to 48 hour after start of infusionin-hospital death

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026